FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jeffrey Lipman

Research Profile

Disorders

Chemicals & Drugs

Objects

Intensive Care Units

Procedures

Concepts & Ideas

Geographic Areas

Australia

Phenomena

Metabolic Clearance Rate

Co-author Network

Publications

TOP 3
Andrew A Udy; Jean-Louis Vincent; Fabio Silvio Taccone; Cecilia Covajes; Frédérique Jacobs; Jeffrey Lipman; Jason A Roberts
Can population pharmacokinetic modelling guide vancomycin dosing during continuous renal replacement therapy in critically ill patients?
Andrew A Udy; Jason A Roberts; Jeffrey Lipman
How should we dose antibiotics for pneumonia in the ICU?
Jason A Roberts; Jeffrey Lipman
Optimal doripenem dosing simulations in critically ill nosocomial pneumonia patients with obesity, augmented renal clearance, and decreased bacterial susceptibility.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jeffrey Lipman (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Andrew A Udy; Jean-Louis Vincent; Fabio Silvio Taccone; Cecilia Covajes; Frédérique Jacobs; Jeffrey Lipman; Jason A Roberts
Can population pharmacokinetic modelling guide vancomycin dosing during continuous renal replacement therapy in critically ill patients?
International journal of antimicrobial agents 2013;41(6):564-8.
2013: Andrew A Udy; Jason A Roberts; Jeffrey Lipman
How should we dose antibiotics for pneumonia in the ICU?
Current opinion in infectious diseases 2013;26(2):189-95.
2013: Jason A Roberts; Jeffrey Lipman
Optimal doripenem dosing simulations in critically ill nosocomial pneumonia patients with obesity, augmented renal clearance, and decreased bacterial susceptibility.
Critical care medicine 2013;41(2):489-95.
2013: Yoshiro Hayashi; Jeffrey Lipman; Karin Lust; Brett McWhinney; Mandy Ng; Andrew A Udy; Jacobus Ungerer; Jason A Roberts
β-Lactam therapeutic drug monitoring in the critically ill: optimising drug exposure in patients with fluctuating renal function and hypoalbuminaemia.
International journal of antimicrobial agents 2013;41(2):162-6.
2013: Jason A Roberts; Federico Pea; Jeffrey Lipman
The clinical relevance of plasma protein binding changes.
Clinical pharmacokinetics 2013;52(1):1-8.
2013: Joel M Dulhunty; Glenn M Eastwood; Charles Gomersall; John Myburgh; David L Paterson; Jason A Roberts; Charudatt Shirwadkar; Steven A R Webb; Rinaldo Bellomo; Joshua S Davis; Jeffrey Lipman
Continuous infusion of beta-lactam antibiotics in severe sepsis: a multicenter double-blind, randomized controlled trial.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2013;56(2):236-44.
2012: Janattul-Ain Jamal; Jeffrey Lipman; Caleb J P Economou; Jason A Roberts
Improving antibiotic dosing in special situations in the ICU: burns, renal replacement therapy and extracorporeal membrane oxygenation.
Current opinion in critical care 2012;18(5):460-71.
2012: J Ostrowski; D L Paterson; Jeffrey Lipman; A A Udy
Blood culture collection in patients with acute kidney injury receiving renal replacement therapy: an observational study.
Anaesthesia and intensive care 2012;40(5):813-9.
2012: Julie M Varghese; Steven C Wallis; Jason A Roberts; Robert J Boots; Robert G Fassett; Helen Healy; Jeffrey Lipman; Dwarakanathan Ranganathan
Pharmacokinetics of intraperitoneal gentamicin in peritoneal dialysis patients with peritonitis (GIPD study).
Clinical journal of the American Society of Nephrology : CJASN 2012;7(8):1249-56.
2012: Bhavik M Patel; David L Paterson; Michael Rudd; Jeffrey Lipman; Anthony Mallet; Michael J Muller; Jennifer Paratz; Jason A Roberts
Characteristics of bloodstream infections in burn patients: An 11-year retrospective study.
Burns : journal of the International Society for Burn Injuries 2012;38(5):685-90.
2012: A A Udy; J A Roberts; M Altukroni; P Jarrett; Jeffrey Lipman
A comparison of pulse contour wave analysis and ultrasonic cardiac output monitoring in the critically ill.
Anaesthesia and intensive care 2012;40(4):631-7.
2012: Andrew A Udy; Jacobus P Ungerer; Julie M Varghese; Mahdi Altukroni; Scott Briscoe; Jeffrey Lipman; Brett C McWhinney; Jason A Roberts
Subtherapeutic initial β-lactam concentrations in select critically ill patients: association between augmented renal clearance and low trough drug concentrations.
Chest 2012;142(1):30-9.
2012: Mahipal G Sinnollareddy; Michael S Roberts; Jeffrey Lipman; Jason A Roberts
β-lactam pharmacokinetics and pharmacodynamics in critically ill patients and strategies for dose optimization: a structured review.
Clinical and experimental pharmacology & physiology 2012;39(6):489-96.
2012: Andrew A Udy; Jan J De Waele; David L Paterson; Jason A Roberts; Jeffrey Lipman
What's behind the failure of emerging antibiotics in the critically ill? Understanding the impact of altered pharmacokinetics and augmented renal clearance.
International journal of antimicrobial agents 2012;39(6):455-7.
2012: Jason A Roberts; Jeffrey Lipman
Editorial commentary: Closing the loop--a colistin clinical study to confirm dosing recommendations from PK/PD modeling.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2012;54(12):1727-9.
2012: Darren M Roberts; Jason A Roberts; Michael S Roberts; Rinaldo Bellomo; Louise Cole; Jeffrey Lipman; Xin Liu; Priya Nair
Variability of antibiotic concentrations in critically ill patients receiving continuous renal replacement therapy: a multicentre pharmacokinetic study.
Critical care medicine 2012;40(5):1523-8.
2012: Anthony Holley; Robert J Boots; Tracey Hawkins; William Lukin; Jennifer Paratz; Jeffrey Lipman
Review article: Part two: Goal-directed resuscitation--which goals? Perfusion targets.
Emergency medicine Australasia : EMA 2012;24(2):127-35.
2012: Bhavik M Patel; David Paterson; Michael Rudd; Natalie C See; Jacobus Ungerer; Scott E Briscoe; Jeffrey Lipman; Brett C McWhinney; Michael J Muller; Jennifer Paratz; Jason A Roberts
Therapeutic drug monitoring of beta-lactam antibiotics in burns patients--a one-year prospective study.
Therapeutic drug monitoring 2012;34(2):160-4.
2012: Jason A Roberts; Gordon Y S Choi; Charles D Gomersall; Gavin M Joynt; Jeffrey Lipman
How to optimise antimicrobial prescriptions in the Intensive Care Unit: principles of individualised dosing using pharmacokinetics and pharmacodynamics.
International journal of antimicrobial agents 2012;39(3):187-92.
2012: Syamhanin Adnan; Suresh Kumar; Janice Li; Jeffrey Lipman; David L Paterson; Michael Rudd; Jason A Roberts
Pharmacokinetics of beta-lactam antibiotics in patients with intra-abdominal disease: a structured review.
Surgical infections 2012;13(1):9-17.
2012: Anthony Holley; Robert J Boots; Tracey Hawkins; William Lukin; Jennifer Paratz; Jeffrey Lipman
Review article: Part one: Goal-directed resuscitation--which goals? Haemodynamic targets.
Emergency medicine Australasia : EMA 2012;24(1):14-22.
2012: Mohd H Abdul-Aziz; Rinaldo Bellomo; Joel M Dulhunty; Jeffrey Lipman; Jason A Roberts
Continuous beta-lactam infusion in critically ill patients: the clinical evidence.
Annals of intensive care 2012;2(1):37.
2012: Fekade Bruck Sime; Michael S Roberts; Jeffrey Lipman; Sandra L Peake; Jason A Roberts
Does Beta-lactam Pharmacokinetic Variability in Critically Ill Patients Justify Therapeutic Drug Monitoring? A Systematic Review.
Annals of intensive care 2012;2(1):35.
2012: Jason A Roberts; Therese Starr; Steven C Wallis; Jan J De Waele; George Dimopoulos; DESPOINA KOULENTI; Claude Martin; Philippe Montravers; jordi rello; Andrew Rhodes; Jeffrey Lipman
DALI: Defining Antibiotic Levels in Intensive care unit patients: a multi-centre point of prevalence study to determine whether contemporary antibiotic dosing for critically ill patients is therapeutic.
BMC infectious diseases 2012;12():152.
2012: Andrew N Ginn; Joan Faoagali; John E Gallagher; Narelle George; Heather F Gidding; Jeffrey Lipman; James S O'Driscoll; Brian I O'Toole; Sally R Partridge; Rita A Perri; Agnieszka M Wiklendt; Jon Iredell
The ecology of antibiotic use in the ICU: homogeneous prescribing of cefepime but not tazocin selects for antibiotic resistant infection.
PloS one 2012;7(6):e38719.
2011: Kashyap Patel; Jason A Roberts; Susan E Tett; Megan E Deldot; Jeffrey Lipman; Carl M J Kirkpatrick
Population pharmacokinetics of fluconazole in critically ill patients receiving continuous venovenous hemodiafiltration: using Monte Carlo simulations to predict doses for specified pharmacodynamic targets.
Antimicrobial agents and chemotherapy 2011;55(12):5868-73.
2011: Shaun Hosein; Andrew A Udy; Jeffrey Lipman
Physiological changes in the critically ill patient with sepsis.
Current pharmaceutical biotechnology 2011;12(12):1991-5.
2011: Andrew A Udy; Michael T Putt; Robert J Boots; Jeffrey Lipman
ARC--augmented renal clearance.
Current pharmaceutical biotechnology 2011;12(12):2020-9.
2011: Alexandra Douglas; Paul Jarrett; Jason Jenkins; Melissa Lassig-Smith; Jeffrey Lipman; Gregory Medley; Michael S Roberts; Janine Stuart; Kersi Taraporewalla; Andrew A Udy; Steven C Wallis; Renae Deans; Jason A Roberts
Plasma and tissue pharmacokinetics of cefazolin in patients undergoing elective and semielective abdominal aortic aneurysm open repair surgery.
Antimicrobial agents and chemotherapy 2011;55(11):5238-42.
2011: Robert J Boots; R Boyd; S Erickson; A Anthony; F Bass; J Beca; M Lassig-Smith; Jeffrey Lipman; D Long; S McGuiness; R Parke; I M Seppelt; Y Shehabi; C Sherring; E R Stachowski; D P Stephens; J Thomas; L Weisbrodt; B Howet
Experience with high frequency oscillation ventilation during the 2009 H1N1 influenza pandemic in Australia and New Zealand.
Anaesthesia and intensive care 2011;39(5):837-46.
2011: Andrew A Udy; Jason A Roberts; Jeffrey Lipman
Implications of augmented renal clearance in critically ill patients.
Nature reviews. Nephrology 2011;7(9):539-43.
2011: Jason A Roberts; Fabio Silvio Taccone; Andrew A Udy; Jean-Louis Vincent; Frédérique Jacobs; Jeffrey Lipman
Vancomycin dosing in critically ill patients: robust methods for improved continuous-infusion regimens.
Antimicrobial agents and chemotherapy 2011;55(6):2704-9.
2011: H Baba; G R Nimmo; Anthony Allworth; R J Boots; Y Hayashi; Jeffrey Lipman; David L Paterson
The role of surveillance cultures in the prediction of susceptibility patterns of Gram-negative bacilli in the intensive care unit.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2011;30(6):739-44.
2011: A M Higgins; Jeffrey Lipman; Ville Pettilä; I M Seppelt; Michael Bailey; A H Harris; Steven A R Webb
The critical care costs of the influenza A/H1N1 2009 pandemic in Australia and New Zealand.
Anaesthesia and intensive care 2011;39(3):384-91.
2011: J M Dulhunty; D Paterson; Steven A R Webb; Jeffrey Lipman
Antimicrobial utilisation in 37 Australian and New Zealand intensive care units.
Anaesthesia and intensive care 2011;39(2):231-7.
2011: Julian M Williams; Jaimi H Greenslade; Kevin Chu; Anthony F T Brown; David Paterson; Jeffrey Lipman
Prior statin use is not associated with improved outcome in emergency patients admitted with infection: a prospective observational study.
Academic emergency medicine : official journal of the Society for Academic Emergency Medicine 2011;18(2):127-34.
2011: Marta Ulldemolins; Jason A Roberts; jordi rello; David L Paterson; Jeffrey Lipman
The effects of hypoalbuminaemia on optimizing antibacterial dosing in critically ill patients.
Clinical pharmacokinetics 2011;50(2):99-110.
2011: Jason A Roberts; Carl M J Kirkpatrick; Jeffrey Lipman
Monte Carlo simulations: maximizing antibiotic pharmacokinetic data to optimize clinical practice for critically ill patients.
The Journal of antimicrobial chemotherapy 2011;66(2):227-31.
2011: Ruqaiya M Al Balushi; Merrilyn Banks; Jeremy Cohen; Joel Dulhunty; Jennifer D Paratz; Jason A Roberts; Jeffrey Lipman
Effect of intravenous GLutamine supplementation IN Trauma patients receiving enteral nutrition study protocol (GLINT Study): a prospective, blinded, randomised, placebo-controlled clinical trial.
BMJ open 2011;1(2):e000334.
2011: João Pedro Baptista; Jorge Pimentel; Jason A Roberts; Eduardo Sousa; Andrew A Udy; Lisa Wang; Jeffrey Lipman
A comparison of estimates of glomerular filtration in critically ill patients with augmented renal clearance.
Critical care (London, England) 2011;15(3):R139.
2011: Alexandra Douglas; Mahdi Altukroni; Andrew A Udy; Michael S Roberts; Kersi Taraporewalla; Jason Jenkins; Jeffrey Lipman; Jason A Roberts
The pharmacokinetics of cefazolin in patients undergoing elective & semi-elective abdominal aortic aneurysm open repair surgery.
BMC anesthesiology 2011;11():5.
2011: Jason A Roberts; Michael S Roberts; Andrew Semark; Andrew A Udy; Carl Mj Kirkpatrick; David L Paterson; Matthew J Roberts; Peter Kruger; Jeffrey Lipman
Antibiotic dosing in the 'at risk' critically ill patient: Linking pathophysiology with pharmacokinetics/pharmacodynamics in sepsis and trauma patients.
BMC anesthesiology 2011;11():3.
2011: Julie M Varghese; Jason A Roberts; Jeffrey Lipman
Antimicrobial pharmacokinetic and pharmacodynamic issues in the critically ill with severe sepsis and septic shock.
Critical care clinics 2011;27(1):19-34.
2010: Jayesh Dhanani; Jason A Roberts; Michelle Chew; Jeffrey Lipman; Robert J Boots; David L Paterson; John F Fraser
Antimicrobial chemotherapy and lung microdialysis: a review.
International journal of antimicrobial agents 2010;36(6):491-500.
2010: A E Douglas; A Holley; A Udy; Jeffrey Lipman; C D Gomersall; G M Joynt; R C Freebairn; Robert J Boots
Can learning to sustain life be BASIC? Teaching for the initial management of the critically ill in Australia and New Zealand.
Anaesthesia and intensive care 2010;38(6):1043-51.
2010: Jason A Roberts; Marta Ulldemolins; Michael S Roberts; Brett McWhinney; Jacobus Ungerer; David L Paterson; Jeffrey Lipman
Therapeutic drug monitoring of beta-lactams in critically ill patients: proof of concept.
International journal of antimicrobial agents 2010;36(4):332-9.
2010: Joel M Dulhunty; Steven A R Webb; David L Paterson; Rinaldo Bellomo; John Myburgh; Jason A Roberts; Jeffrey Lipman
A survey of antibiotic prescribing practices in Australian and New Zealand intensive care units.
Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine 2010;12(3):162-70.
2010: Jason A Roberts; Jonathan Field; Adam Visser; Rosemary Whitbread; Mandy Tallot; Jeffrey Lipman; Carl M J Kirkpatrick
Using population pharmacokinetics to determine gentamicin dosing during extended daily diafiltration in critically ill patients with acute kidney injury.
Antimicrobial agents and chemotherapy 2010;54(9):3635-40.
2010: Yoshiro Hayashi; Jason A Roberts; David L Paterson; Jeffrey Lipman
Pharmacokinetic evaluation of piperacillin-tazobactam.
Expert opinion on drug metabolism & toxicology 2010;6(8):1017-31.
2010: Marta Ulldemolins; Jason A Roberts; Steven C Wallis; jordi rello; Jeffrey Lipman
Flucloxacillin dosing in critically ill patients with hypoalbuminaemia: special emphasis on unbound pharmacokinetics.
The Journal of antimicrobial chemotherapy 2010;65(8):1771-8.
2010: Julie M Varghese; Jason A Roberts; Jeffrey Lipman
Pharmacokinetics and pharmacodynamics in critically ill patients.
Current opinion in anaesthesiology 2010;23(4):472-8.
2010: Vikram Patil; Joel M Dulhunty; Andrew Udy; Peter Thomas; Geraldine Kucharski; Jeffrey Lipman
Do burn patients cost more? The intensive care unit costs of burn patients compared with controls matched for length of stay and acuity.
Journal of burn care & research : official publication of the American Burn Association 2010;31(4):598-602.
2010: I Bilgrami; Jason A Roberts; S C Wallis; J Thomas; J Davis; S Fowler; P B Goldrick; Jeffrey Lipman
Meropenem dosing in critically ill patients with sepsis receiving high-volume continuous venovenous hemofiltration.
Antimicrobial agents and chemotherapy 2010;54(7):2974-8.
2010: Andrew A Udy; Michael T Putt; Sulochana Shanmugathasan; Jason A Roberts; Jeffrey Lipman
Augmented renal clearance in the Intensive Care Unit: an illustrative case series.
International journal of antimicrobial agents 2010;35(6):606-8.
2010: Jason A Roberts; William W Hope; Jeffrey Lipman
Therapeutic drug monitoring of beta-lactams for critically ill patients: unwarranted or essential?
International journal of antimicrobial agents 2010;35(5):419-20.
2010: Michelle Doidge; Anthony M Allworth; Marion Woods; Penelope Marshall; Michael Terry; Kathryn O'Brien; Hwee Mian Goh; Narelle George; Graeme R Nimmo; Mark A Schembri; Jeffrey Lipman; David L Paterson
Control of an outbreak of carbapenem-resistant Acinetobacter baumannii in Australia after introduction of environmental cleaning with a commercial oxidizing disinfectant.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2010;31(4):418-20.
2010: Jason A Roberts; Carl M J Kirkpatrick; Michael S Roberts; Andrew J Dalley; Jeffrey Lipman
First-dose and steady-state population pharmacokinetics and pharmacodynamics of piperacillin by continuous or intermittent dosing in critically ill patients with sepsis.
International journal of antimicrobial agents 2010;35(2):156-63.
2010: Gordon Choi; Charles D Gomersall; Qi Tian; Gavin M Joynt; Alexander M M Y Li; Jeffrey Lipman
Principles of antibacterial dosing in continuous renal replacement therapy.
Blood purification 2010;30(3):195-212.
2010: Andrew A Udy; Jason A Roberts; Robert J Boots; David L Paterson; Jeffrey Lipman
Augmented renal clearance: implications for antibacterial dosing in the critically ill.
Clinical pharmacokinetics 2010;49(1):1-16.
2009: Jeffrey Lipman; Robert J Boots
A new paradigm for treating infections: "go hard and go home".
Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine 2009;11(4):276-81.
2009: Gregor B S McNeill; Anthony Holley; Jeffrey Lipman
Emphysematous pyelonephritis: an unusual complication of blunt abdominal trauma.
Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine 2009;11(4):269-71.
2009: Andrew J Dalley; Renae Deans; Jeffrey Lipman; Bala Venkatesh; Michael Rudd; Michael S Roberts; Sheree E Cross
Unbound cephalothin pharmacokinetics in adult burn patients are related to the elapsed time after injury.
Antimicrobial agents and chemotherapy 2009;53(12):5303-5.
2009: I Chatterjee; J M Dulhunty; Jon Iredell; J E Gallagher; A Sud; M Woods; Jeffrey Lipman
Predictors and outcome associated with an Enterococcus positive isolate during intensive care unit admission.
Anaesthesia and intensive care 2009;37(6):976-82.
2009: Gordon Choi; Charles D Gomersall; Qi Tian; Gavin M Joynt; Ross Freebairn; Jeffrey Lipman
Principles of antibacterial dosing in continuous renal replacement therapy.
Critical care medicine 2009;37(7):2268-82.
2009: Jason A Roberts; Carl M J Kirkpatrick; Michael S Roberts; Thomas A Robertson; Andrew J Dalley; Jeffrey Lipman
Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution.
The Journal of antimicrobial chemotherapy 2009;64(1):142-50.
2009: Jason A Roberts; Steven Webb; David Paterson; Kwok M Ho; Jeffrey Lipman
A systematic review on clinical benefits of continuous administration of beta-lactam antibiotics.
Critical care medicine 2009;37(6):2071-8.
2009: Anthony Holley; Joel Dulhunty; Stijn Blot; Jeffrey Lipman; Suzana Lobo; Craig Dancer; jordi rello; George Dimopoulos
Temporal trends, risk factors and outcomes in albicans and non-albicans candidaemia: an international epidemiological study in four multidisciplinary intensive care units.
International journal of antimicrobial agents 2009;33(6):554.e1-7.
2009: A Udy; S Senthuran; Jeffrey Lipman
Airway obstruction due to a pre-vertebral haematoma following difficult central line insertion--implications for ultrasound guidance and review of the literature.
Anaesthesia and intensive care 2009;37(2):309-13.
2009: Jason A Roberts; Michael S Roberts; Thomas A Robertson; Andrew J Dalley; Jeffrey Lipman
Piperacillin penetration into tissue of critically ill patients with sepsis--bolus versus continuous administration?
Critical care medicine 2009;37(3):926-33.
2009: Jason A Roberts; Jeffrey Lipman
Pharmacokinetic issues for antibiotics in the critically ill patient.
Critical care medicine 2009;37(3):840-51; quiz 859.
2009: Jeremy Cohen; Renae Deans; Andrew Dalley; Jeffrey Lipman; Michael S Roberts; Bala Venkatesh
Measurement of tissue cortisol levels in patients with severe burns: a preliminary investigation.
Critical care (London, England) 2009;13(6):R189.
2009: Andrew J Dalley; Jeffrey Lipman; Renae Deans; Bala Venkatesh; Michael Rudd; Michael S Roberts; Sheree E Cross
Tissue accumulation of cephalothin in burns: a comparative study by microdialysis of subcutaneous interstitial fluid cephalothin concentrations in burn patients and healthy volunteers.
Antimicrobial agents and chemotherapy 2009;53(1):210-5.
2008: Joel M Dulhunty; Robert J Boots; Michael J Rudd; Michael J Muller; Jeffrey Lipman
Increased fluid resuscitation can lead to adverse outcomes in major-burn injured patients, but low mortality is achievable.
Burns : journal of the International Society for Burn Injuries 2008;34(8):1090-7.
2008: Joel M Dulhunty; Jeffrey Lipman; Simon Finfer
Does severe non-infectious SIRS differ from severe sepsis? Results from a multi-centre Australian and New Zealand intensive care unit study.
Intensive care medicine 2008;34(9):1654-61.
2008: Jason A Roberts; Jeffrey Lipman; Stijn I Blot; jordi rello
Better outcomes through continuous infusion of time-dependent antibiotics to critically ill patients?
Current opinion in critical care 2008;14(4):390-6.
2008: Jason A Roberts; Peter Kruger; David L Paterson; Jeffrey Lipman
Antibiotic resistance--what's dosing got to do with it?
Critical care medicine 2008;36(8):2433-40.
2008: D M Roberts; J A Roberts; Robert J Boots; R Mason; Jeffrey Lipman
Lessons learnt in the pharmacokinetic analysis of the effect of haemoperfusion for acute overdose with sustained-release diltiazem.
Anaesthesia 2008;63(7):714-8.
2008: Jason A Roberts; Michael S Roberts; Thomas A Robertson; Sheree E Cross; Jeffrey Lipman
A novel way to investigate the effects of plasma exchange on antibiotic levels: use of microdialysis.
International journal of antimicrobial agents 2008;31(3):240-4.
2007: Jason A Roberts; Jeffrey Lipman
Optimizing use of beta-lactam antibiotics in the critically ill.
Seminars in respiratory and critical care medicine 2007;28(6):579-85.
2007: D Freshwater-Turner; A Udy; Jeffrey Lipman; Renae Deans; J Stuart; Robert J Boots; R Hegde; B C McWhinney
Autonomic dysfunction in tetanus - what lessons can be learnt with specific reference to alpha-2 agonists?
Anaesthesia 2007;62(10):1066-70.
2007: Peter J Thomas; Jennifer Paratz; Jeffrey Lipman; Warren R Stanton
Lateral positioning of ventilated intensive care patients: a study of oxygenation, respiratory mechanics, hemodynamics, and adverse events.
Heart & lung : the journal of critical care 2007;36(4):277-86.
2007: Andrew J Dalley; Jeffrey Lipman; Bala Venkatesh; Michael Rudd; Michael S Roberts; Sheree E Cross
Inadequate antimicrobial prophylaxis during surgery: a study of beta-lactam levels during burn debridement.
The Journal of antimicrobial chemotherapy 2007;60(1):166-9.
2007: Jason A Roberts; Jennifer Paratz; Elizabeth Paratz; Wolfgang A Krueger; Jeffrey Lipman
Continuous infusion of beta-lactam antibiotics in severe infections: a review of its role.
International journal of antimicrobial agents 2007;30(1):11-8.
2007: Juliana F Roos; Jeffrey Lipman; Carl M J Kirkpatrick
Population pharmacokinetics and pharmacodynamics of cefpirome in critically ill patients against Gram-negative bacteria.
Intensive care medicine 2007;33(5):781-8.
2007: Indranil Chatterjee; Jon Iredell; Marion Woods; Jeffrey Lipman
The implications of enterococci for the intensive care unit.
Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine 2007;9(1):69-75.
2007: A Holley; M Cartner; Jeffrey Lipman
Acute respiratory distress in a bleomycin primed patient: a new use for nitric oxide.
Anaesthesia and intensive care 2007;35(1):86-90.
2007: Jason A Roberts; Rob Boots; Claire M Rickard; Peter Thomas; Jo Quinn; Darren M Roberts; Brent Richards; Jeffrey Lipman
Is continuous infusion ceftriaxone better than once-a-day dosing in intensive care? A randomized controlled pilot study.
The Journal of antimicrobial chemotherapy 2007;59(2):285-91.
2007: J Dhanani; S Senthuran; R Olivotto; Robert J Boots; Jeffrey Lipman
The entrapped central venous catheter.
British journal of anaesthesia 2007;98(1):89-92.
2006: Peter J Thomas; Jennifer Paratz; Warren R Stanton; Renae Deans; Jeffrey Lipman
Positioning practices for ventilated intensive care patients: current practice, indications and contraindications.
Australian critical care : official journal of the Confederation of Australian Critical Care Nurses 2006;19(4):122-6, 128, 130-2.
2006: Juliana F Roos; Jürgen Bulitta; Jeffrey Lipman; Carl M J Kirkpatrick
Pharmacokinetic-pharmacodynamic rationale for cefepime dosing regimens in intensive care units.
The Journal of antimicrobial chemotherapy 2006;58(5):987-93.
2006: Qi Tian; Charles D Gomersall; April Wong; Patricia Leung; Gordon Choi; Gavin M Joynt; Perpetua Tan; Jeffrey Lipman
Effect of drug concentration on adsorption of levofloxacin by polyacrylonitrile haemofilters.
International journal of antimicrobial agents 2006;28(2):147-50.
2006: Jennifer Paratz; Jeffrey Lipman
Manual hyperinflation causes norepinephrine release.
Heart & lung : the journal of critical care 2006;35(4):262-8.
2006: Jason A Roberts; Jeffrey Lipman
Antibacterial dosing in intensive care: pharmacokinetics, degree of disease and pharmacodynamics of sepsis.
Clinical pharmacokinetics 2006;45(8):755-73.
2005: J Li; craig rayner; Roger L Nation; Renae Deans; Robert J Boots; N Widdecombe; A Douglas; Jeffrey Lipman
Pharmacokinetics of colistin methanesulfonate and colistin in a critically ill patient receiving continuous venovenous hemodiafiltration.
Antimicrobial agents and chemotherapy 2005;49(11):4814-5.
2005: I J Rechner; Jeffrey Lipman
The costs of caring for patients in a tertiary referral Australian Intensive Care Unit.
Anaesthesia and intensive care 2005;33(4):477-82.
2005: Andries Gous; Jeffrey Lipman; Juan Scribante; Shephelia Tshukutsoane; Hubert Hon; Mary Pinder; Rudo Mathivha; Lia Verhoef; Heino Stass
Fluid shifts have no influence on ciprofloxacin pharmacokinetics in intensive care patients with intra-abdominal sepsis.
International journal of antimicrobial agents 2005;26(1):50-5.
2005: Jon Iredell; Jeffrey Lipman
Antibiotic resistance in the intensive care unit: a primer in bacteriology.
Anaesthesia and intensive care 2005;33(2):188-95.
2005: Robert J Boots; Jeffrey Lipman; R Bellomo; D Stephens; R E Heller
Predictors of physician confidence to diagnose pneumonia and determine illness severity in ventilated patients. Australian and New Zealand practice in intensive care (ANZPIC II).
Anaesthesia and intensive care 2005;33(1):112-9.
2005: Robert J Boots; Jeffrey Lipman; R Bellomo; D Stephens; R F Heller
Disease risk and mortality prediction in intensive care patients with pneumonia. Australian and New Zealand practice in intensive care (ANZPIC II).
Anaesthesia and intensive care 2005;33(1):101-11.
2005: Robert J Boots; Jeffrey Lipman; R Bellomo; D Stephens; R E Heller
The spectrum of practice in the diagnosis and management of pneumonia in patients requiring mechanical ventilation. Australian and New Zealand practice in intensive care (ANZPIC II).
Anaesthesia and intensive care 2005;33(1):87-100.
2004: Gordon Choi; Charles D Gomersall; Jeffrey Lipman; April Wong; Gavin M Joynt; Patricia Leung; Sarah J Ramsay; Oi Man Ho
The effect of adsorption, filter material and point of dilution on antibiotic elimination by haemofiltration an in vitro study of levofloxacin.
International journal of antimicrobial agents 2004;24(5):468-72.
2004: Megan E DelDot; Jeffrey Lipman; Susan E Tett
Vancomycin pharmacokinetics in critically ill patients receiving continuous venovenous haemodiafiltration.
British journal of clinical pharmacology 2004;58(3):259-68.
2004: Claire M Rickard; Jeffrey Lipman; Mary Courtney; Rosemary Siversen; Peter J P Daley
Routine changing of intravenous administration sets does not reduce colonization or infection in central venous catheters.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2004;25(8):650-5.
2004: Natasha Koroloff; Robert J Boots; Jeffrey Lipman; Peter Thomas; Claire M Rickard; Fiona Coyer
A randomised controlled study of the efficacy of hypromellose and Lacri-Lube combination versus polyethylene/Cling wrap to prevent corneal epithelial breakdown in the semiconscious intensive care patient.
Intensive care medicine 2004;30(6):1122-6.
2003: Jeffrey Lipman; Steven C Wallis; Robert J Boots
Cefepime versus cefpirome: the importance of creatinine clearance.
Anesthesia and analgesia 2003;97(4):1149-54, table of contents.
2002: RJ Boots; Jeffrey Lipman
High dependency units: issues to consider in their planning.
Anaesthesia and intensive care 2002;30(3):348-54.
2002: Jeffrey Lipman; A G S Gous; L R Mathivha; Shephelia Tshukutsoane; Juan Scribante; Hubert Hon; M Pinder; J F Riera-Fanego; L Verhoef; Heino Stass
Ciprofloxacin pharmacokinetic profiles in paediatric sepsis: how much ciprofloxacin is enough?
Intensive care medicine 2002;28(4):493-500.
2002: Claire M Rickard; Steven C Wallis; Mary Courtney; Jeffrey Lipman; Peter J P Daley
Intravascular administration sets are accurate and in appropriate condition after 7 days of continuous use: an in vitro study.
Journal of advanced nursing 2002;37(4):330-7.
2001: Steven C Wallis; D V Mullany; Jeffrey Lipman; Claire M Rickard; Peter J P Daley
Pharmacokinetics of ciprofloxacin in ICU patients on continuous veno-venous haemodiafiltration.
Intensive care medicine 2001;27(4):665-72.
2001: Gavin M Joynt; Jeffrey Lipman; Charles D Gomersall; R J Young; E L Y Wong; Tony Gin
The pharmacokinetics of once-daily dosing of ceftriaxone in critically ill patients.
The Journal of antimicrobial chemotherapy 2001;47(4):421-9.
2001: Jeffrey Lipman; Steven C Wallis; Claire M Rickard; David Fraenkel
Low cefpirome levels during twice daily dosing in critically ill septic patients: pharmacokinetic modelling calls for more frequent dosing.
Intensive care medicine 2001;27(2):363-70.
2000: Jeffrey Lipman
Towards better ICU antibiotic dosing.
Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine 2000;2(4):282-9.
2000: Jeffrey Lipman; Anthony Allworth; Steven C Wallis
Cerebrospinal fluid penetration of high doses of intravenous ciprofloxacin in meningitis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2000;31(5):1131-3.
2000: David Fraenkel; Claire M Rickard; Jeffrey Lipman
Can we achieve consensus on central venous catheter-related infections?
Anaesthesia and intensive care 2000;28(5):475-90.
2000: RJ Boots; Jeffrey Lipman; J O'Callaghan; P Scott; J Fraser
The treatment of tetanus with intrathecal baclofen.
Anaesthesia and intensive care 2000;28(4):438-42.
1999: Jeffrey Lipman; Steven C Wallis; Claire M Rickard
Low plasma cefepime levels in critically ill septic patients: pharmacokinetic modeling indicates improved troughs with revised dosing.
Antimicrobial agents and chemotherapy 1999;43(10):2559-61.
1999: A R Jones; Bala Venkatesh; Jeffrey Lipman
Vancomycin resistance in gram-positive cocci--old bugs, new tricks, confusing terminology.
Anaesthesia and intensive care 1999;27(4):396-9.
1999: Jeffrey Lipman; C D Gomersall; Tony Gin; Gavin M Joynt; R J Young
Continuous infusion ceftazidime in intensive care: a randomized controlled trial.
The Journal of antimicrobial chemotherapy 1999;43(2):309-11.
1998: Juan Scribante; Jeffrey Lipman; R Saadia
Good clinical research practice: what is it and is it possible in the intensive care unit?
Anaesthesia and intensive care 1998;26(5):568-74.
1998: Jeffrey Lipman; Juan Scribante; A G Gous; Hubert Hon; Shephelia Tshukutsoane
Pharmacokinetic profiles of high-dose intravenous ciprofloxacin in severe sepsis. The Baragwanath Ciprofloxacin Study Group.
Antimicrobial agents and chemotherapy 1998;42(9):2235-9.
1998: M Pinder; Shephelia Tshukutsoane; Juan Scribante; R Piccolo; Jeffrey Lipman
Critical care research and pre-emptive informed consent: a practical approach used in Chris Hani Baragwanath ICU.
Intensive care medicine 1998;24(4):353-7.
1997: R J Young; Jeffrey Lipman; Tony Gin; Charles D Gomersall; Gavin M Joynt; Teik E Oh
Intermittent bolus dosing of ceftazidime in critically ill patients.
The Journal of antimicrobial chemotherapy 1997;40(2):269-73.
1997: Gavin M Joynt; Jeffrey Lipman; Charles D Gomersall; I Tan; Juan Scribante
Gastric intramucosal pH and blood lactate in severe sepsis.
Anaesthesia 1997;52(8):726-32.